Drug intelligence / Profile preview

2-fluoroadenine

Development stage
Preclinical
Modality
Small Molecules
Administration
None, Research Chemical Only
01

Overview

**2-fluoroadenine** is a fluorinated adenine antimetabolite and purine nucleoside analog. It is cytotoxic and has been studied mainly as a research tool for cancer and gene therapy applications. It acts by interfering with nucleic acid synthesis, leading to inhibition of cell growth and induction of cell death. In research, it has been used to select cells or organisms deficient in adenine phosphoribosyltransferase (APT) by exploiting its toxicity to wild-type cells. It can be used in the synthesis of heat shock protein 90 (Hsp90) inhibitors with anticancer activity, acts broadly as an antineoplastic agent, and has also been investigated for suicide gene therapy in human malignancy. Its cytotoxicity is notable in human leukemia cells, with an IC50 of 0.15 µM[1][2][7].

Other names
2-fluoro-9H-purin-6-amine2-fluoro-7H-purin-6-amine2-faduoroadenine2-fluoro-adenin2-FLUOROADENINE2-Fluoro-6-aminopurine2-Fluoro-1H-purin-6-amine9H-Adenine, 2-fluoro-Adenine, 2-fluoro-(VAN)2-fluorohydropurine-6-ylamineSCHEMBL8850SCHEMBL-8850SCHEMBL 8850SCHEMBL8851SCHEMBL-8851SCHEMBL 8851
02

Targets

APRT (Adenine phosphoribosyltransferase)

Beyond the preview

Go deeper on 2-fluoroadenine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 2-fluoroadenine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call